AbbVie
ABBV
1,503 hedge funds and large institutions have $72.7B invested in AbbVie in 2014 Q3 according to their latest regulatory filings, with 106 funds opening new positions, 581 increasing their positions, 589 reducing their positions, and 49 closing their positions.
143% more call options, than puts
Call options by funds: $1.09B | Put options by funds: $449M
116% more first-time investments, than exits
New positions opened: 106 | Existing positions closed: 49
16% more funds holding in top 10
Funds holding in top 10: 69 → 80 (+11)
14% more capital invested
Capital invested by funds: $63.8B → $72.7B (+$8.88B)
7.96% more ownership
Funds ownership: 71.1% → 79.06% (+8%)
3% more funds holding
Funds holding: 1,457 → 1,503 (+46)
1% less repeat investments, than reductions
Existing positions increased: 581 | Existing positions reduced: 589
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.35B |
| 2 |
SC
Sculptor Capital
New York
|
+$847M |
| 3 |
PC
Paulson & Co
New York
|
+$722M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$598M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$538M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$634M |
| 2 |
D.E. Shaw & Co
New York
|
-$312M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$278M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$203M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$196M |
ABBV Hedge Fund Activity: Q3 2014 in Review
1,503 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2014, worth a combined $72.7B — up 14% from $63.8B a quarter earlier.
Buyers outnumbered sellers: 106 funds opened new ABBV positions and 49 closed out — a net gain of 57 holders — while 581 added to existing stakes and 589 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $1.35B. The largest seller was Norges Bank, cutting an estimated $634M.
- 1,503 institutional investors held AbbVie (ABBV) as of Q3 2014, up from 1,457 in Q2 2014.
- Funds reported $72.7B of AbbVie stock for Q3 2014, up 14% quarter-over-quarter.
- 106 funds opened new AbbVie positions in Q3 2014 and 49 closed out, a net change of +57 holders.
- The largest AbbVie buyer in Q3 2014 was Fidelity Investments, an estimated $1.35B added.
- The largest AbbVie seller in Q3 2014 was Norges Bank, an estimated $634M sold.
Based on aggregated 13F filings for Q3 2014.